AAM
Azzad Asset Management’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-9,384
| Closed | -$274K | – | 311 |
|
|
2024
Q1 | $274K | Buy |
9,384
+185
| +2% | +$5.41K | 0.03% | 284 |
|
|
2023
Q4 | $310K | Buy |
+9,199
| New | +$310K | 0.04% | 288 |
|
|
2023
Q3 | – | Sell |
-6,204
| Closed | -$249K | – | 318 |
|
|
2023
Q2 | $249K | Buy |
6,204
+158
| +3% | +$6.33K | 0.03% | 308 |
|
|
2023
Q1 | $247K | Buy |
6,046
+239
| +4% | +$9.75K | 0.04% | 303 |
|
|
2022
Q4 | $224K | Buy |
5,807
+77
| +1% | +$2.97K | 0.04% | 300 |
|
|
2022
Q3 | $305K | Buy |
5,730
+1,798
| +46% | +$95.6K | 0.03% | 372 |
|
|
2022
Q2 | $229K | Buy |
3,932
+82
| +2% | +$4.78K | 0.02% | 382 |
|
|
2022
Q1 | $294K | Sell |
3,850
-917
| -19% | -$70K | 0.04% | 307 |
|
|
2021
Q4 | $287K | Sell |
4,767
-20
| -0.4% | -$1.2K | 0.04% | 315 |
|
|
2021
Q3 | $268K | Buy |
4,787
+115
| +2% | +$6.44K | 0.04% | 312 |
|
|
2021
Q2 | $284K | Sell |
4,672
-62
| -1% | -$3.76K | 0.04% | 306 |
|
|
2021
Q1 | $332K | Buy |
4,734
+94
| +2% | +$6.59K | 0.06% | 289 |
|
|
2020
Q4 | $278K | Buy |
4,640
+164
| +4% | +$9.82K | 0.05% | 271 |
|
|
2020
Q3 | $269K | Buy |
+4,476
| New | +$269K | 0.06% | 273 |
|